The Clinical Research Management Office (CRMO) shared resource operates from a centralized Lombardi Cancer Center facility which is dedicated to the support of programmatic clinical investigations. Personnel in the CRMO work under the direction of the core's supervisor to support all operational aspects of clinical research protocols, from the inception of a study design to publication of the results. The main functions of the CRMO include: 1) quality assurance and compliance with protocol guidelines; 2) identification of patients for study; 3) education of clinical fellows and nurses in trial design and conduct; 4) accurate and complete data collection; and 5) interfacing with other relevant groups such as the Institutional Review Board, Pharmacy, Georgetown University Hospital Tumor Registry, and the Biostatistics Shared Resource. The CRMO provides centralization, consistency, cost-effectiveness, and quality control for resources and service activities that are critical to the conduct of clinical research. It is the intent of the CRMO to provide a service to peer-review funded programs of the cancer center. Research programs in breast cancer, bone marrow transplantation, AIDS, experimental therapeutics, hematology/lymphoma, radiation oncology, prostate cancer, and the developmental programs of gynecological oncology, neuro-oncology, and psycho-oncology have received support in the conduct of clinical trials from CRMO personnel.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA051008-04
Application #
3773527
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Shiao-Pieng; Kao, Chen-Yu; Chang, Shun-Cheng et al. (2018) Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. PLoS One 13:e0192632
Paffhausen, Emily S; Alowais, Yasir; Chao, Cara W et al. (2018) Discovery of a stem-like multipotent cell fate. Am J Stem Cells 7:25-37
Akinyemiju, Tomi F; Demb, Joshua; Izano, Monika A et al. (2018) The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review. Int J Public Health 63:787-797
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Furth, Priscilla A (2018) Peroxisome proliferator-activated receptor gamma and BRCA1. Endocr Relat Cancer :
Sehrawat, Archana; Gao, Lina; Wang, Yuliang et al. (2018) LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A 115:E4179-E4188
Gusev, Yuriy; Bhuvaneshwar, Krithika; Song, Lei et al. (2018) The REMBRANDT study, a large collection of genomic data from brain cancer patients. Sci Data 5:180158
Oppong, Bridget A; Dash, Chiranjeev; O'Neill, Suzanne et al. (2018) Breast density in multiethnic women presenting for screening mammography. Breast J 24:334-338
Fernandez, Harvey R; Gadre, Shreyas M; Tan, Mingjun et al. (2018) The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death Differ 25:1239-1258
Schmidt, Marcel Oliver; Garman, Khalid Ammar; Lee, Yong Gu et al. (2018) The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation. J Invest Dermatol 138:179-188

Showing the most recent 10 out of 1120 publications